FDA to review Actelions Zavesca for additional use (Reuters)

Reuters - Actelion Ltd, Europes largest biotech company, said on Thursday the U.S. Food and Drug Administration (FDA) would review use of its drug Zavesca to treat a rare neurodegenerative disease early next year.